|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
3.600 +0.080 (+2.273%) Ranking Overview
Ranking based on 10 research report(s)
Average Ranking 2.30
|
Strong Buy (1)
0
|
Buy (2)
8
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 03/2024 | EPS | 6.29 RMB (cts) | |
| Net Profit | 883.48 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,628.85 | 10.50 | 0 | -- | 1,876.80 | 1,548.00 |
| 2026 | 2,251.00 | 15.00 | 0 | -- | 2,468.30 | 1,788.00 |
| 2027 | 2,872.50 | 20.00 | 0 | -- | 3,158.01 | 2,237.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 1,557.00 | 12.00 | -- | HAITONG | OutPerform | 6.34 | 04/06/2024 | |
| 2025 | 1,627.70 | 12.60 | -- | UOB | Buy | 5.00 | 15/11/2024 | |
| 2025 | 1,576.00 | 10.00 | -- | MORGAN STANLEY | Overweight | 5.00 | 21/11/2024 | |
| 2025 | 1,630.00 | 10.00 | -- | CLSA | OutPerform | 4.80 | 14/11/2024 | |
| 2025 | 1,611.00 | 10.00 | -- | CICC | OutPerform | 4.70 | 17/11/2024 | |
| 2025 | 1,796.74 | 11.00 | -- | HSBC | Buy | 4.50 | 18/11/2024 | |
| 2025 | 1,876.80 | 13.00 | -- | GOLDMAN SACHS | Buy | 4.40 | 18/06/2024 | |
| 2025 | 1,548.00 | 10.00 | -- | HUATAI FIN HLDGS HK | Buy | 4.40 | 15/11/2024 | |
| 2025 | 1,819.00 | 10.00 | -- | MACQUARIE | UnderPerform | 3.40 | 15/11/2024 | |
| 2025 | 1,754.00 | 11.00 | -- | UBS | Neutral | 3.30 | 20/08/2024 | |
| 2026 | 1,956.00 | 15.00 | -- | HAITONG | -- | -- | 04/06/2024 | |
| 2026 | 2,432.40 | 17.00 | -- | UOB | -- | -- | 15/11/2024 | |
| 2026 | 2,210.00 | 14.00 | -- | MORGAN STANLEY | -- | -- | 21/11/2024 | |
| 2026 | 2,215.00 | 10.00 | -- | CLSA | -- | -- | 14/11/2024 | |
| 2026 | 1,788.00 | 11.00 | -- | CICC | -- | -- | 17/11/2024 | |
| 2026 | 2,347.78 | 15.00 | -- | HSBC | -- | -- | 18/11/2024 | |
| 2026 | 1,929.00 | 12.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 15/11/2024 | |
| 2026 | 2,468.30 | 17.00 | -- | GOLDMAN SACHS | -- | -- | 18/06/2024 | |
| 2026 | 2,287.00 | 20.00 | -- | MACQUARIE | -- | -- | 15/11/2024 | |
| 2026 | 2,392.00 | 15.00 | -- | UBS | -- | -- | 20/08/2024 | |
| 2027 | 2,884.00 | 18.00 | -- | MORGAN STANLEY | -- | -- | 21/11/2024 | |
| 2027 | 3,122.20 | 21.50 | -- | UOB | -- | -- | 15/11/2024 | |
| 2027 | 2,861.00 | 20.00 | -- | CLSA | -- | -- | 14/11/2024 | |
| 2027 | 3,158.01 | 20.00 | -- | HSBC | -- | -- | 18/11/2024 | |
| 2027 | 2,887.80 | 20.00 | -- | GOLDMAN SACHS | -- | -- | 18/06/2024 | |
| 2027 | 2,237.00 | 14.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 15/11/2024 | |
| 2027 | 2,649.00 | 20.00 | -- | MACQUARIE | -- | -- | 15/11/2024 | |
| 2027 | 2,825.00 | 18.00 | -- | UBS | -- | -- | 20/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 26/11/2024 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 768,953 |
| %Change | 72.453% |
| EPS / (LPS) | RMB 0.048 |
| NBV Per Share (¥) | RMB 0.949 |